Protagonist Therapeutics, Inc. revenue breakdown overview

Protagonist Therapeutics, Inc. revenue for the last year amounted to 434.43 M USD, the most of which — 434.43 M USD — came from its highest performing source at the moment, Peptide Therapeutics, the year earlier bringing 60.00 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Protagonist Therapeutics, Inc. 434.43 M USD, and the year before that — 60.00 M USD.